Sigrid Naess
Overview
Explore the profile of Sigrid Naess including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weismuller T, Trivedi P, Bergquist A, Imam M, Lenzen H, Ponsioen C, et al.
Gastroenterology
. 2017 Mar;
152(8):1975-1984.e8.
PMID: 28274849
Background & Aims: Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct...
2.
3.
Vukcevic D, Traherne J, Naess S, Ellinghaus E, Kamatani Y, Dilthey A, et al.
Am J Hum Genet
. 2015 Oct;
97(4):593-607.
PMID: 26430804
Large population studies of immune system genes are essential for characterizing their role in diseases, including autoimmune conditions. Of key interest are a group of genes encoding the killer cell...
4.
Vesterhus M, Hov J, Holm A, Schrumpf E, Nygard S, Godang K, et al.
Hepatology
. 2015 Apr;
62(1):188-97.
PMID: 25833813
Unlabelled: There is a need to determine biomarkers reflecting disease activity and prognosis in primary sclerosing cholangitis (PSC). We evaluated the prognostic utility of the enhanced liver fibrosis (ELF) score...
5.
Naess S, Lie B, Melum E, Olsson M, Hov J, Croucher P, et al.
PLoS One
. 2014 Dec;
9(12):e114486.
PMID: 25521205
Background: Genetic variants within the major histocompatibility complex (MHC) represent the strongest genetic susceptibility factors for primary sclerosing cholangitis (PSC). Identifying the causal variants within this genetic complex represents a...
6.
Fosby B, Naess S, Hov J, Traherne J, Boberg K, Trowsdale J, et al.
World J Gastroenterol
. 2014 Apr;
20(14):3986-4000.
PMID: 24744588
Aim: To investigate influence of human leukocyte antigen (HLA) and killer immunoglobuline-like receptor (KIR) genotypes on risks of acute rejection (AR) after liver transplantation (LTX). Methods: In this retrospective study...
7.
Naess S, Bjornsson E, Anmarkrud J, Mamari S, Juran B, Lazaridis K, et al.
Liver Int
. 2014 Feb;
34(10):1488-95.
PMID: 24517468
Background & Aims: Small duct primary sclerosing cholangitis (PSC) is phenotypically a mild version of large duct PSC, but it is unknown whether these phenotypes share aetiology. We aimed to...
8.
Liu J, Hov J, Folseraas T, Ellinghaus E, Rushbrook S, Doncheva N, et al.
Nat Genet
. 2013 Apr;
45(6):670-5.
PMID: 23603763
Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation. We compared...
9.
Naess S, Shiryaev A, Hov J, Franke A, Karlsen T
Clin Res Hepatol Gastroenterol
. 2012 May;
36(4):325-33.
PMID: 22554879
Primary sclerosing cholangitis (PSC) is a chronic cholestatic disorder with a progressive course. PSC is strongly associated with inflammatory bowel disease and is often complicated by cholangiocarcinoma development. Etiology and...